Searched for
M K HAMIED
Cipla's vice-chairman MK Hamied resigns citing age and health, his son Kamil to join the boardCipla's vice-chairman MK Hamied has resigned from the board due to age and health concerns, effective October 29, 2024. His son Kamil Hamie...- Cipla's MK Hamied resigns from the company due to health reasonsCipla's Vice Chairman and Non-Executive Director, Mr. M K Hamied, has resigned from his position due to age and health reasons. His resigna...
- Samina Hamied of Cipla steps down from her executive roleSamina Hamied, executive vice-chairperson of Cipla, announced her decision to step down from her executive role due to personal and family ...
- Torrent joins fray for Hamied family stake in Cipla, up against Blackstone and Baring PETorrent Pharma is reportedly vying to acquire the Hamied family's stake in Cipla, which could become the largest pharmaceutical deal since ...
- Buy Cipla., target price Rs 1022: ICICI DirectPrice closed above previous gap down area suggest further upsides in coming sessions.
- Buy Cipla, target price Rs 1,090: ICICI DirectICICI Direct has issued a buy call on Cipla with a target price of Rs 1090, higher than the current market price of Rs 914.45. Analysts pro...
- Motilal Oswal Financial Services neutral on Cipla; target price- Rs 990Cipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 72606.20 Crore) operating in Pharmaceuticals sector.
- Hold Cipla, target price Rs 1080: Sharekhan by BNP ParibasCipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 77400.61 Crore) operating in Pharmaceuticals sector.
- Hold Cipla, target price Rs 1080: Sharekhan by BNP ParibasCipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 77566.07 Crore) operating in Pharmaceuticals sector.
- Buy Cipla, target price Rs 1260: Axis SecuritiesCipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 86522.68 Crore) operating in Pharmaceuticals sector.
- Buy Cipla, target price Rs 1230: Axis SecuritiesCipla key Products/Revenue Segments include Pharmaceuticals, Royalty Income, Other Operating Revenue, Export Incentives and Scrap for the y...
- Hold Cipla, target price Rs 1210: Sharekhan by BNP ParibasCipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 89460.16 Crore) operating in Pharmaceuticals sector.
- Motilal Oswal Financial Services neutral on CiplaCipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 88524.04 Crore) operating in Pharmaceuticals sector.
- Sell Cipla, target Rs 625: Jay ThakkarSell Cipla Ltd. at a price target of Rs 625 and a stop loss at Rs 651 from the entry point.
- Buy Cipla, target Rs 625: Dr CK NarayanBuy Cipla at a price target of Rs 625 and a stop loss at Rs 605 from entry point.
- A perfect throwback birthday celebration for YK Hamied, Chairman, CiplaHamied celebrated his 81st birthday last week.
- Cipla elevates Samina Vaziralli to its boardCipla today announced the appointment of Samina Vaziralli as executive director on its board, paving way for a bigger role for her.
- Cipla promoter family gets Sebi go-ahead for voting agreementCipla's promoter family has proposed to vote together as a single unit under overall direction of patriarch Yusuf Hamied in his lifetime, a...
- Cipla chief Yusuf K Hamied grooms niece & nephew Samina Vaziralli & Kamil Hamied as genext leadersEven as Hamied prepares genext leaders for Cipla, it’s humanitarian face is out to shake up industry by delivering affordable biosimilar dr...
- Cipla board approves retirement of MK HamiedDrug firm Cipla today approved the retirement of its Executive Vice-Chairman, M K Hamied with effect from March 31, 2014.
Load More
